Dr Arijit Bishnu is the best haemato- onchologist in Siliguri, with great skills and friendly nature.
Immunotherapy is a type of cancer treatment that uses the body's immune system to fight hematologic cancers, such as leukemia, lymphoma, and myeloma. Unlike traditional therapies, which often target cancer cells directly, immunotherapy enhances or alters the body's immune response to more effectively identify and destroy malignant cells. This innovative approach includes several different types of therapies, such as monoclonal antibodies, immune checkpoint inhibitors, chimeric antigen receptor T-cell (CAR-T) therapy, and cancer vaccines. Monoclonal antibodies, for example, are lab-created molecules that can bind to specific proteins on the surface of cancer cells, helping the immune system recognize and attack them. Immune checkpoint inhibitors, on the other hand, work by blocking the mechanisms that allow cancer cells to evade immune detection, thus enhancing the immune system's ability to fight tumors. CAR-T therapy, a particularly promising development, involves modifying a patient’s own T-cells to better recognize and attack cancer cells, offering hope for patients with certain types of leukemia and lymphoma that have not responded to other treatments.
While immunotherapy has shown remarkable promise in improving survival rates and even achieving remission for some hematologic cancers, it does come with potential side effects, such as immune-related adverse events, including inflammation of organs or tissues. As a result, careful monitoring and management by specialized healthcare teams are essential. Despite these risks, immunotherapy continues to represent a significant advancement in the treatment of blood cancers, offering a personalized and highly effective approach for many patients who have limited options with traditional therapies.
Dr. Arijit Bishnu and his team use advanced diagnostics, such as genetic testing and molecular profiling, to determine whether targeted therapy is right for a patient. Treatment is then closely monitored and adjusted based on response and tolerance :
Medical History Review: Understanding your symptoms, lifestyle, and medical history to assess any underlying conditions that may be contributing to the menstrual issues.
Treatment of specific blood cancers - Used in conditions such as chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), certain lymphomas, and myeloproliferative neoplasms.
Molecular targeting - Focuses on proteins, genes, or cellular pathways that drive abnormal blood cell growth or survival.
Genetic testing required -Requires molecular diagnostics to identify the presence of targetable mutations or markers.
Fewer side effects than chemotherapy - Typically spares normal cells, leading to lower risk of hair loss, nausea, or widespread immune suppression.
Key advancement in personalized medicine - Allows hematologists to match treatment to each patient’s unique disease profile for optimal outcomes.
Dr. Arijit Bishnu specializes in the diagnosis and treatment of blood disorders, including anemia, leukemia, lymphoma, and clotting abnormalities. With expertise in advanced haematological care, he is dedicated to providing accurate diagnosis and personalized treatment plans for optimal patient health.
© Dr. Arijit Bishnu. All Rights Reserved.
Designed by Digiex Web